Due to the crucial role of PI3Ks in regulating cell cycle, metabolism, and survival, the PI3K signaling cascade in human leukemias is one of the most often altered pathways [18, 19] and different compounds targeting members of the PI3K network have been developed and entered clinical trials [20]. The gene discussed is PIK3CD; the disease is leukemia.